Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Wall Street Breakfast Podcast: Flight Cuts Deepen On Fuel Shock
07:05am, Monday, 13'th Apr 2026
Airlines are cutting global flight schedules for April and May as Iran-driven energy disruptions elevate fuel costs and operational uncertainty. Tesla (TSLA) secured its first European approval for Fu
GSK sees blockbuster potential in targeted cancer therapy after promising early data
10:12am, Sunday, 12'th Apr 2026
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early data showed the drug helped shrink tumors i
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
10:53am, Friday, 10'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Douglas Lane & Associates LLC Cuts Holdings in GSK PLC Sponsored ADR $GSK
04:20am, Friday, 10'th Apr 2026
Douglas Lane and Associates LLC reduced its position in GSK PLC Sponsored ADR (NYSE: GSK) by 6.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Com
Generic versions of the drug will still be available to treat a rare genetic condition.
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
11:01am, Tuesday, 07'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
10:00am, Tuesday, 31'st Mar 2026
Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expandi
GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
08:45am, Thursday, 26'th Mar 2026
GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
Broker reiterates GSK 'buy' as court ruling lifts vaccine cloud
10:17am, Wednesday, 25'th Mar 2026
Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the pharmaceutical group's shares are too cheap given the scale of its growth a
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer
11:56am, Monday, 23'rd Mar 2026
GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
Here's Why GSK (GSK) is a Strong Value Stock
10:41am, Thursday, 19'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
US FDA approves GSK's drug for liver disease related itching
08:08am, Thursday, 19'th Mar 2026
The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by a type of liver disease, the company said on Thursday, making it the
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
GSK Expanding Fast - Oncology, HIV, And Smart Acquisitions
08:00am, Wednesday, 18'th Mar 2026
GSK, with Luke Miels becoming its new CEO in early 2026, continues its successful expansion into the oncology and cardiovascular drugs markets. So, on February 25, GSK announced that it acquired 35Pha
GSK's RSV Vaccine Arexvy Wins FDA Nod for High-Risk Younger Adults
02:20pm, Monday, 16'th Mar 2026
GSK secures FDA approval to expand Arexvy's use to high-risk adults aged 18-49 years, broadening access as the company pushes wider global adoption.
